[Anhydrohydroxyprogesterone therapy of the Rh-negative pregnant].
D035843:Biomedical Research; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005003:Ethisterone; D005260:Female; D005333:Fetus; D006402:Hematologic Diseases; D006801:Humans; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D013739:Testosterone / Q000031:analogs & derivatives
D012204:Rh-Hr Blood-Group System; D013739:Testosterone; D005003:Ethisterone
ERYTHROBLASTOSIS, FETAL/prevention and control; RH FACTORS; TESTOSTERONE/derivatives
Tratamento de gestantes Rhnegativas com anidridroxiprogesterona.